Skip to main content
Caplight Logo









HotHouse Therapeutics

HotHouse Therapeutics

Private
NorwichHealthcare & Life Scienceshttps://hothousetx.com/

Last Round

Pre Seed

Dec 2, 2025

Total Funding Raised

$3.88M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

HotHouse Therapeutics is a biotechnology company that develops plant-based therapeutics using AI-driven biosynthetic pathways.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Pharma Supply Chain

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Government Contracts

AI Layer

Application

Keywords

AI drug discoveryvaccine adjuvantssaponin adjuvantsdrug discovery platformmolecular farmingQS-21synthetic biologytransient plant expressionbio-manufacturinggenerative biologymolecule discoverynew-to-nature moleculespharma supply chainimmuno-oncology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

HotHouse Therapeutics Comparables

Compare HotHouse Therapeutics with similar companies based on industry and business-model similarity.

HotHouse Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ImmunAdd Inc.
81%
Adjuvance Technologies
77%
Leaf Expression Systems
77%

HotHouse Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedDec 2, 2025

HotHouse Therapeutics Investors

Notable investors and investment history

HotHouse Therapeutics investors
InvestorRounds
Future Planet Capital RegionalPre Seed
Start CodonPre Seed
SynBioVenPre Seed
Innovate UKPre Seed
Twin Path VenturesPre Seed
Wren CapitalPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 2, 2025

    $4M round led by SynBioVen.

HotHouse Therapeutics Filings

Explore SEC and related filing metadata, where available.

HotHouse Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about HotHouse Therapeutics's valuation, stock price, and market status.

Is HotHouse Therapeutics a public or private company?

HotHouse Therapeutics is a private company.

What is the current stock price of HotHouse Therapeutics?

HotHouse Therapeutics is a private company with no public stock price. No recent secondary market data is available.

How much is HotHouse Therapeutics worth (valuation)?

Valuation information for HotHouse Therapeutics is not publicly available.

Can I buy HotHouse Therapeutics stock?

HotHouse Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was HotHouse Therapeutics's last funding round?

HotHouse Therapeutics's most recent funding round was Pre Seed on December 2, 2025.

Who are the main investors in HotHouse Therapeutics?

Key investors in HotHouse Therapeutics include SynBioVen.

Will HotHouse Therapeutics IPO soon?

No public IPO plans have been announced for HotHouse Therapeutics.

How can I track HotHouse Therapeutics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor HotHouse Therapeutics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNorwich
Year Founded2020
Last FundingDec 2, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?